Preoperative chemotherapy with carboplatin alone in high risk medulloblastoma.

Few studies have been carried out regarding preoperative chemotherapy utilized in the treatment of primitive neuroectodermal tumors/medulloblastomas (PNET/MB). In this paper, the authors report 3 cases of children under three years of age, with a presumed diagnosis of PNET/MB, who were preoperatively treated with chemotherapy consisting of high doses of carboplatin alone. The treatment improved the childrens' clinical condition prior to surgery and facilitated tumor removal, resulting in partial regression of the tumor. The preoperative single-drug therapy did not affect the histological diagnosis or prevent the presence of an effective degree of tumor sensitivity to the drug. All three children are still disease-free, after a mean follow-up period of 42 months.
AuthorsC Di Rocco, A Iannelli, F La Marca, A Tornesello, S Mastrangelo, R Riccardi
JournalChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (Childs Nerv Syst) Vol. 11 Issue 10 Pg. 574-8 (Oct 1995) ISSN: 0256-7040 [Print] GERMANY
PMID8556723 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Carboplatin
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Carboplatin (administration & dosage, adverse effects)
  • Cerebellar Neoplasms (drug therapy, pathology, surgery)
  • Cerebellum (pathology, surgery)
  • Chemotherapy, Adjuvant
  • Child, Preschool
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Male
  • Medulloblastoma (drug therapy, pathology, surgery)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: